Northwest & Ethical Investments’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-6,655
Closed -$251K 366
2019
Q4
$251K Buy
6,655
+195
+3% +$8.76K 0.01% 367
2019
Q3
$301K Buy
6,460
+139
+2% +$6.46K 0.01% 359
2019
Q2
$330K Buy
6,321
+2,926
+86% +$172K 0.02% 351
2019
Q1
$234K Buy
3,395
+951
+39% +$63.8K 0.01% 356
2018
Q4
$146K Buy
+2,444
New +$211K 0.01% 360

Other funds holding CLB

Northwest & Ethical Investments's CLB Position: Q1 2020 in Review

Northwest & Ethical Investments sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 6,655 shares — an estimated $251K sold.

Northwest & Ethical Investments first reported a position in CLB in Q4 2018 and held it in 5 quarters. The position peaked at $330K in Q2 2019. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

  • Northwest & Ethical Investments reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
  • Northwest & Ethical Investments sold 6,655 Core Laboratories shares in Q1 2020, an estimated $251K.
  • Northwest & Ethical Investments first reported a position in Core Laboratories in Q4 2018 and held it in 5 quarters.
  • Northwest & Ethical Investments's Core Laboratories position peaked at $330K in Q2 2019.
  • 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Northwest & Ethical Investments's 13F filing for Q1 2020, filed 8 Jul 2025.